Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the period ending March 31, 2021. The report details a capital increase approved by the Board of Directors on March 29, 2021, resulting from the exercise of stock options under the company's 2021 Stock Option Plan.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes and historical share pricing.
- Capital Increase Amount: BRL 1,611,304.58
- New Capital Stock: BRL 57,973,874,024.26
- New Shares Issued: 141,929 common shares (no par value)
- Issuance Price: BRL 14.02 per share
Material Changes
The primary material change is the issuance of 141,929 new common shares. This transaction resulted in a potential dilution of 0.000730% in relation to the number of shares and 0.002779% in relation to the capital stock. The filing includes historical share price data for the last three years, two years (quarterly), and six months (monthly), noting that prices are adjusted for interest on own capital and dividend distributions.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors related to operations. The document is a procedural notice regarding the homologation of a capital increase pursuant to Brazilian Law No. 6,404/76 and the Company's Bylaws.
Investor Verification Checklist
- Verify the impact of the 141,929 new shares on total outstanding share count.
- Confirm the issuance price of BRL 14.02 against the market price on the exercise date.
- Review the updated capital stock total of BRL 57,973,874,024.26.
- Note that the filing does not contain operational financial results for Q1 2021.